Skip to main content
. 2016 Jul 21;26(3):345–354. doi: 10.18865/ed.26.3.345

Table 4. Percentage of risk factors among HF patients by age and ethnicity in 2007 and 2010.

Age 20-34 34-44 45-54 55-64 65-74 75-84 ≥85 All Ages Total Sample
Ethnic Group B/H/W B/H/W B/H/W B/H/W B/H/W B/H/W B/H/W B/H/W
Col. → 1 2 3 4 5 6 7 8 9
HTN 2007 80/60/62 88/79/66 91/85/76 93/90/80 94/92/84 94/91/84 93/89/82 92/89/82 85
2010 83a/72/60 88a/82/66 91a/86/76 94a/90/82 95a/92/85 94a/92/87 94a/90/85 93a/90/84 87
DM 2007 26/30/19 36/41/33 45/63/44 55/75/56 61/75/56 57/64/44 38/44/26 51/64/41 47
2010 29a/27/21 34/44a/31 45/62a/40 55/75a/53 62/76a/55 54/65a/43 40/45a/26 51/64a/40 47
CHOL 2007 6/4/5 10/10/7 12/16/11 16/18/16 16/19/17 16/16/15 12/14/12 14/16/14 14
2010 3/4/2 8/6/6 9/11b/8 9/13b/11 13/14/11 11/14/12 10/12/9 10/13a/11 11
CHD 2007 18/19/15 32/30/28 42/47/47 56/61/61 62/70/70 63/70/70 58/64/61 53/62/64 62
2010 24/22/20 30/30/31 43/47/44 50/57/58 58/66/67 63/70a/68 59/63/60 51/60/62a 60
MI 2007 3/3/4 5/5/5 7/7/8 9/11/11 10/12/12 11/12/11 10/11/11 9/11/11 10
2010 7/4/3 6/6/5 6/8/8 7/10/9 10/11/10 11/12/10 11/11/9 9/10/10 10
STK 2007 6/4/4 6/4/4 8/8/7 12/11/9 16/15/13 18/16/14 18/15/13 13/13/12 13
2010 4/5/3 7/5/4 9/8/7 12/9/8 14a/12/11 18a/14/13 20a/12/12 13a11/11 12
AFib 2007 31/31/35 38/25/37 34/30/43 40/39/49 50/49/60 57/56/58 57/29/68 44/47/62 56
2010 29/32/33 29/28/36a 37/30/42a 43/37/48a 48/46/60a 54/57/69a 59/58/69a 45/47/63a 57
CKD 2007 42/36/32 43/40/21 42/43/28 47/52/36 55/53/43 53/51/44 52/43/40 49/49/40 43
2010 46a/39/27 42a/39/24 47/48a/30 54a/54/40 60a/60/50 64a57/53 63a/52/50 56a/54/48 50
COPD 2007 19/15/15 24/15/25 34/21/37 41/27/44 44/33/48 41/31/43 36/37/35 38/31/41 38
2010 19/17/31a 17/20/30a 20/20/27a 20/20/29a 17/21/26a 14/20/22 12/19/19 37/30/39 37

a. Differences between ethnic groups within the age category are significant at P≤.001.

b. Differences between ethnic groups within the age category are significant at P<.01.

B, Blacks; W, Whites; H, Hispanics; HTN, hypertension; DM, diabetes mellitus; CHOL, high cholesterol; CHD, coronary heart disease; MI, myocardial infarction; STRK, stroke; AFib, atrial fibrillation; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease.